Rivaroxaban Once-Daily vs. Dose-Adjusted Vitamin K Antagonist on Biomarkers in Acute Decompensated Heart Failure and Atrial Fibrillation (ROAD HF-AF): Rationale and Design of an Investigator-Initiated Multicenter Randomized Prospective Open-Labeled Pilot Clinical Study

Iksung Cho, Jaewon Oh, In Cheol Kim, Hyemoon Chung, Jung Hee Lee, Hyue Mee Kim, Young Sup Byun, Byung Su Yoo, Eui Young Choi, Wook Jin Chung, Wook Bum Pyun, Seok Min Kang

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Rivaroxaban Once-Daily vs. Dose-Adjusted Vitamin K Antagonist on Biomarkers in Acute Decompensated Heart Failure and Atrial Fibrillation (ROAD HF-AF): Rationale and Design of an Investigator-Initiated Multicenter Randomized Prospective Open-Labeled Pilot Clinical Study'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science